| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |